Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-23-000044
Filing Date
2023-05-09
Accepted
2023-05-09 16:07:43
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20230331.htm   iXBRL 10-Q 1216795
2 RULE 13A-14(A) CERTIFICATION CEO exhibit311ceoq12023.htm EX-31.1 10806
3 RULE 13A-14(A) CERTIFICATION CFO exhibit312cfoq12023.htm EX-31.2 10781
4 SECTION 1350 CERTIFICATIONS exhibit321ceocfoq12023.htm EX-32.1 7110
  Complete submission text file 0001787306-23-000044.txt   6759622

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20230331.xsd EX-101.SCH 49693
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20230331_cal.xml EX-101.CAL 68123
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20230331_def.xml EX-101.DEF 229588
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20230331_lab.xml EX-101.LAB 632947
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20230331_pre.xml EX-101.PRE 414432
66 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20230331_htm.xml XML 1067126
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 23901981
SIC: 2834 Pharmaceutical Preparations